<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Immunolocalization of the tumor-sensitive calmodulin-like protein CALML3 in normal human skin and hyperproliferative skin disorders.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Immunolocalization of the tumor-sensitive calmodulin-like protein CALML3 in normal human skin and hyperproliferative skin disorders." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95d/3630146/10d4660c1f47/pone.0062347.g002.jpg"/> </div> <div class="text-side"> <h1>Immunolocalization of the tumor-sensitive calmodulin-like protein CALML3 in normal human skin and hyperproliferative skin disorders.</h1> <p>Variable CALML3 and Ki-67 expression in actinic keratosis.Different AK specimens were stained for CALML3, Ki-67, and H&amp;E as indicated. (A) Example of an AK with moderate proliferation and strong CALML3 immunoreactivity but loss of CALML3 nuclear reactivity. (B) AK with mild hyperproliferation confined to the basal layer and robust CALML3 immunoreactivity in the basal and suprabasal layers with nuclear accumulation in the thickened non-proliferative layers (arrows in CALML3-stained panel). (C) Highly proliferative AK with reduced and patchy CALML3 staining in the basal and suprabasal layers and loss of CALML3 nuclear immunoreactivity. This lesion may represent a transition to SCC (see Fig. 3). The images in panels A, B, and C are representative of 2, 3, and 1 of the 6 samples analyzed, respectively.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/23638045/" target="_blank">23638045</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>